These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22908174)

  • 21. Development of decreased susceptibility to daptomycin and vancomycin in a Staphylococcus aureus strain during prolonged therapy.
    Mariani PG; Sader HS; Jones RN
    J Antimicrob Chemother; 2006 Aug; 58(2):481-3. PubMed ID: 16847029
    [No Abstract]   [Full Text] [Related]  

  • 22. [Osteomyelitis associated with Staphylococcus aureus infection and reduced susceptibility to vancomycin treated with daptomycin].
    Araujo F; Conde Estevez D; Encinas Barrios C
    Farm Hosp; 2012; 36(5):449-51. PubMed ID: 22484104
    [No Abstract]   [Full Text] [Related]  

  • 23. [DISTRIBUTION AND DRUG SENSITIVITY OF PATHOGENS IN PATIENTS WITH PROSTHETIC JOINT INFECTION AFTER PRIMARY TOTAL KNEE ARTHROPLASTY].
    Yang Y; Yang F; Zhang Z; Li H; Chen J
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2014 Jul; 28(7):848-52. PubMed ID: 26462348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.
    Marty FM; Yeh WW; Wennersten CB; Venkataraman L; Albano E; Alyea EP; Gold HS; Baden LR; Pillai SK
    J Clin Microbiol; 2006 Feb; 44(2):595-7. PubMed ID: 16455920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Daptomycin compared to vancomycin for the treatment of osteomyelitis: a single-center, retrospective cohort study.
    Moenster RP; Linneman TW; Finnegan PM; McDonald JR
    Clin Ther; 2012 Jul; 34(7):1521-7. PubMed ID: 22748973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical progression of methicillin-resistant Staphylococcus aureus vertebral osteomyelitis associated with reduced susceptibility to daptomycin.
    Vikram HR; Havill NL; Koeth LM; Boyce JM
    J Clin Microbiol; 2005 Oct; 43(10):5384-7. PubMed ID: 16208025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes with daptomycin in the treatment of Staphylococcus aureus infections with a range of vancomycin MICs.
    Crompton JA; North DS; Yoon M; Steenbergen JN; Lamp KC; Forrest GN
    J Antimicrob Chemother; 2010 Aug; 65(8):1784-91. PubMed ID: 20554570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis.
    Gerber P; Stucki A; Acosta F; Cottagnoud M; Cottagnoud P
    J Antimicrob Chemother; 2006 Apr; 57(4):720-3. PubMed ID: 16459345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure.
    Kelley PG; Gao W; Ward PB; Howden BP
    J Antimicrob Chemother; 2011 May; 66(5):1057-60. PubMed ID: 21393156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Daptomycin Exposure and Efficacy and Safety Endpoints To Support Risk-versus-Benefit Considerations.
    Bhavnani SM; Ambrose PG; Hammel JP; Rubino CM; Drusano GL
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1600-7. PubMed ID: 26711755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Daptomycin non-susceptible Staphylococcus aureus at a US medical centre.
    Velazquez A; DeRyke CA; Goering R; Hoover V; Wallace MR
    Clin Microbiol Infect; 2013 Dec; 19(12):1169-72. PubMed ID: 23480569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic.
    Cosgrove SE; Vigliani GA; Fowler VG; Abrutyn E; Corey GR; Levine DP; Rupp ME; Chambers HF; Karchmer AW; Boucher HW
    Clin Infect Dis; 2009 Mar; 48(6):713-21. PubMed ID: 19207079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Telavancin for the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis.
    Twilla JD; Gelfand MS; Cleveland KO; Usery JB
    J Antimicrob Chemother; 2011 Nov; 66(11):2675-7. PubMed ID: 21831987
    [No Abstract]   [Full Text] [Related]  

  • 34. Microbiological profile and outcomes of two-stage revision hip arthroplasty.
    Hariharan TD; Chandy VJ; George J; Mathew AJ; Premnath J; Pragasam AK; Prakash JJ; Oomen AT; Poonnoose PM
    Indian J Med Microbiol; 2019; 37(1):67-71. PubMed ID: 31424013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tolerability and efficacy of long-term treatment with daptomycin, ceftazidime and colistin in a patient with a polymicrobial, multidrug-resistant prosthetic joint reinfection: a case report.
    Pasticci MB; Di Filippo P; Pasqualini L; Mencacci A; Pallotto C; Malincarne L; Baldelli F
    J Med Case Rep; 2014 Jun; 8():186. PubMed ID: 24923703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial.
    Tong SYC; Lye DC; Yahav D; Sud A; Robinson JO; Nelson J; Archuleta S; Roberts MA; Cass A; Paterson DL; Foo H; Paul M; Guy SD; Tramontana AR; Walls GB; McBride S; Bak N; Ghosh N; Rogers BA; Ralph AP; Davies J; Ferguson PE; Dotel R; McKew GL; Gray TJ; Holmes NE; Smith S; Warner MS; Kalimuddin S; Young BE; Runnegar N; Andresen DN; Anagnostou NA; Johnson SA; Chatfield MD; Cheng AC; Fowler VG; Howden BP; Meagher N; Price DJ; van Hal SJ; O'Sullivan MVN; Davis JS;
    JAMA; 2020 Feb; 323(6):527-537. PubMed ID: 32044943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ceftaroline in the treatment of concomitant methicillin-resistant and daptomycin-non-susceptible Staphylococcus aureus infective endocarditis and osteomyelitis: case report.
    Jongsma K; Joson J; Heidari A
    J Antimicrob Chemother; 2013 Jun; 68(6):1444-5. PubMed ID: 23341127
    [No Abstract]   [Full Text] [Related]  

  • 38. Different microbiological profiles between hip and knee prosthetic joint infections.
    Tsai Y; Chang CH; Lin YC; Lee SH; Hsieh PH; Chang Y
    J Orthop Surg (Hong Kong); 2019; 27(2):2309499019847768. PubMed ID: 31117922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intermediate vancomycin susceptibility in a community-associated MRSA clone.
    Graber CJ; Wong MK; Carleton HA; Perdreau-Remington F; Haller BL; Chambers HF
    Emerg Infect Dis; 2007 Mar; 13(3):491-3. PubMed ID: 17552110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Daptomycin for treating infected diabetic foot ulcers: evidence from a randomized, controlled trial comparing daptomycin with vancomycin or semi-synthetic penicillins for complicated skin and skin-structure infections.
    Lipsky BA; Stoutenburgh U
    J Antimicrob Chemother; 2005 Feb; 55(2):240-5. PubMed ID: 15659542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.